126 related articles for article (PubMed ID: 19112430)
1. Study of photodynamic efficiency of the hematoporphyrin conjugated with antibody to VEGF in mouse Lewis carcinoma.
Novichenko NL; Mamchur AA; Lisniak IO; Gamaliya MF
Exp Oncol; 2008 Dec; 30(4):315-8. PubMed ID: 19112430
[TBL] [Abstract][Full Text] [Related]
2. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
[TBL] [Abstract][Full Text] [Related]
3. Effect of photodynamic therapy on tumor angiogenesis and metastasis in mice bearing Lewis lung carcinoma.
Lisnjak IO; Kutsenok VV; Polyschuk LZ; Gorobets OB; Gamaleia NF
Exp Oncol; 2005 Dec; 27(4):333-5. PubMed ID: 16404357
[TBL] [Abstract][Full Text] [Related]
4. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
5. Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance.
Pyaskovskaya ON; Dasyukevich OI; Kolesnik DL; Garmanchouk LV; Todor IN; Solyanik GI
Exp Oncol; 2007 Sep; 29(3):197-202. PubMed ID: 18004244
[TBL] [Abstract][Full Text] [Related]
6. Chronobiological approaches to antiangiogenic photodynamic therapy of tumors: the first experimental evaluation.
Gamaleia NF; Lisnyak IA; Shishko ED; Mamchur AA; Prokopenko IV; Kholin VV
Exp Oncol; 2012 Dec; 34(4):364-6. PubMed ID: 23302997
[TBL] [Abstract][Full Text] [Related]
7. Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy.
Stott B; Korbelik M
Cancer Immunol Immunother; 2007 May; 56(5):649-58. PubMed ID: 16947020
[TBL] [Abstract][Full Text] [Related]
8. [Photodynamic therapy of experimental tumors using 5-aminolevulinic acid].
Hamaliia MF; Kutsenok VV; Horobets' OB; Lozyns'kyĭ MO; Borysevych AM; Kholin VV
Fiziol Zh (1994); 2005; 51(5):65-70. PubMed ID: 16329395
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic activity of hematoporphyrin conjugates with gold nanoparticles: experiments in vitro.
Gamaleia NF; Shishko ED; Dolinsky GA; Shcherbakov AB; Usatenko AV; Kholin VV
Exp Oncol; 2010 Mar; 32(1):44-7. PubMed ID: 20332758
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
11. [The effect of VEGF antisense oligonucleotides combined with low molecular weight heparin on the growth and metastasis of mice Lewis lung cancer].
Zhang YH; Wang C; Pang BS; Zhai ZG; Weng XZ
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):749-52. PubMed ID: 16681948
[TBL] [Abstract][Full Text] [Related]
12. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy of esophageal varices: experimental studies in animal veins, and first clinical cases.
Li CZ; Cheng LF; Wang ZQ; Gu Y
Endoscopy; 2003 Dec; 35(12):1043-8. PubMed ID: 14648419
[TBL] [Abstract][Full Text] [Related]
14. [Photodynamic therapy of pigmented choroidal melanomas in rabbits using hematoporphyrin monomethyl ether].
Ji HX; Zhang F; Gao LQ; Jia LY; Xiong Y; Liang C; Li LQ
Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):212-6. PubMed ID: 17605902
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice].
Li XH; Tang L; Liu D; Sun HM; Zhou CC; Tan LS; Wang LP; Zhang PD; Zhang SQ
Ai Zheng; 2006 Oct; 25(10):1221-6. PubMed ID: 17059764
[TBL] [Abstract][Full Text] [Related]
17. [History of photodynamic therapy--past, present and future].
Kato H
Gan To Kagaku Ryoho; 1996 Jan; 23(1):8-15. PubMed ID: 8546474
[TBL] [Abstract][Full Text] [Related]
18. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
19. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
20. 5-aminolevulinic acid mediated photodynamic therapy of Lewis lung carcinoma: a role of tumor infiltration with different cells of immune system.
Skivka LM; Gorobets OB; Kutsenok VV; Lozinsky MO; Borisevich AN; Fedorchuk AG; Kholin VV; Gamaleya NF
Exp Oncol; 2004 Dec; 26(4):312-5. PubMed ID: 15627065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
